1. A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first‐line therapy administration in patients with chronic lymphocytic leukemia. (28th November 2022) Authors: Vodárek, Pavel; Écsiová, Dominika; Řezáčová, Vladimíra; Souček, Ondřej; Šimkovič, Martin; Vokurková, Doris; Belada, David; Žák, Pavel; Smolej, Lukáš Journal: Cancer medicine Issue: Volume 12:Number 6(2023) Page Start: 6956 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alternating R‐CHOP and R‐cytarabine is a safe and effective regimen for transplant‐ineligible patients with a newly diagnosed mantle cell lymphoma. Issue 1 (30th October 2017) Authors: Klener, Pavel; Fronkova, Eva; Belada, David; Forsterova, Kristina; Pytlik, Robert; Kalinova, Marketa; Simkovic, Martin; Salek, David; Mocikova, Heidi; Prochazka, Vit; Blahovcova, Petra; Janikova, Andrea; Markova, Jana; Obr, Ales; Berkova, Adela; Kubinyi, Jozef; Vaskova, Martina; Mejstrikova, Este... Journal: Hematological oncology Issue: Volume 36:Issue 1(2018) Page Start: 110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial. Issue 10168 (19th January 2019) Authors: Horwitz, Steven; O'Connor, Owen A; Pro, Barbara; Illidge, Tim; Fanale, Michelle; Advani, Ranjana; Bartlett, Nancy L; Christensen, Jacob Haaber; Morschhauser, Franck; Domingo-Domenech, Eva; Rossi, Giuseppe; Kim, Won Seog; Feldman, Tatyana; Lennard, Anne; Belada, David; Illés, Árpád; Tobinai, Kense... Journal: Lancet Issue: Volume 393:Issue 10168(2019) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind, placebo-controlled phase 2b trial. Issue 9 (2nd September 2015) Authors: Fayad, Luis; Ansell, Stephen M.; Advani, Ranjana; Coiffier, Bertrand; Stuart, Robert; Bartlett, Nancy L.; Forero-Torres, Andres; Kuliczkowski, Kazimierz; Belada, David; Ng, Edmund; Drachman, Jonathan G. Journal: Leukemia & lymphoma Issue: Volume 56:Issue 9(2015:Sep.) Page Start: 2569 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study. Issue 4 (April 2015) Authors: Cheah, Chan Yoon; Belada, David; Fanale, Michelle A; Janikova, Andrea; Czucman, Myron S; Flinn, Ian W; Kapp, Amy V; Ashkenazi, Avi; Kelley, Sean; Bray, Gordon L; Holden, Scott; Seymour, John F Journal: Lancet Issue: Volume 2:Issue 4(2015) Page Start: e166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database. Issue 3 (4th March 2017) Authors: Procházka, Vít; Papajík, Tomáš; Janíková, Andrea; Belada, David; Kozák, Tomáš; Šálek, David; Sýkorová, Alice; Móciková, Heidi; Campr, Vít; Dlouhá, Jitka; Langová, Kateřina; Fürst, Tomáš; Trněný, Marek Journal: Leukemia & lymphoma Issue: Volume 58:Issue 3(2017) Page Start: 601 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database. Issue 5 (3rd May 2016) Authors: Janikova, Andrea; Bortlicek, Zbynek; Campr, Vit; Kopalova, Natasa; Benesova, Katerina; Hamouzova, Jitka; Belada, David; Prochazka, Vit; Pytlik, Robert; Vokurka, Samuel; Pirnos, Jan; Duras, Juraj; Mocikova, Heidi; Mayer, Jiri; Trneny, Marek Journal: Leukemia & lymphoma Issue: Volume 57:Issue 5(2016:May) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial. Issue 3 (March 2016) Authors: Trněný, Marek; Lamy, Thierry; Walewski, Jan; Belada, David; Mayer, Jiri; Radford, John; Jurczak, Wojciech; Morschhauser, Franck; Alexeeva, Julia; Rule, Simon; Afanasyev, Boris; Kaplanov, Kamil; Thyss, Antoine; Kuzmin, Alexej; Voloshin, Sergey; Kuliczkowski, Kazimierz; Giza, Agnieszka; Milpied, No... Journal: Lancet oncology Issue: Volume 17:Issue 3(2016:Mar.) Page Start: 319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Low‐dose fludarabine and cyclophosphamide combined with rituximab in the first‐line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long‐term results of project Q‐lite by the Czech CLL Study Group. (22nd February 2021) Authors: Smolej, Lukáš; Brychtová, Yvona; Cmunt, Eduard; Doubek, Michael; Špaček, Martin; Belada, David; Šimkovič, Martin; Stejskal, Lukáš; Zygulová, Irena; Urbanová, Renata; Brejcha, Martin; Zuchnická, Jana; Móciková, Heidi; Kozák, Tomáš Journal: British journal of haematology Issue: Volume 193:Number 4(2021) Page Start: 769 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry†. Issue 3 (23rd February 2019) Authors: Obr, Aleš; Prochazka, Vit; Papajik, Tomas; Klener, Pavel; Janikova, Andrea; Salek, David; Belada, David; Pytlík, Robert; Sykorova, Alice; Mocikova, Heidi; Simkovic, Martin; Campr, Vit; Dlouha, Jitka; Furst, Tomas; Trněný, Marek Journal: Leukemia & lymphoma Issue: Volume 60:Issue 3(2019) Page Start: 748 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗